Peptide questions · Efinopegdutide
How long does efinopegdutide take to work?
Reviewed Evidence: ModeratePublished by PepVault
Efinopegdutide’s onset is weeks, its peak effect comes at 24–52 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
The timeline’s basis: Phase 2b MASH (Lawitz 2026, Lancet; NCT05877547), phase 2a vs semaglutide (Romero-Gómez 2023, J Hepatol), phase 2 obesity (Alba 2021, Clin Obes), development history (Hope 2021, Front Endocrinol). Investigational.
Efinopegdutide week by week
The library places five of its research notes on efinopegdutide on the days they cover, from day 1 to day 364: 5 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | A gentle first month | Randomized trial |
| Days 29–364 (weeks 5–52) | Four milligrams | Randomized trial |
| Days 57–364 (weeks 9–52) | The dose the trial favoured | Randomized trial |
| Days 57–364 (weeks 9–52) | Weight comes down too | Randomized trial |
| Days 85–364 (weeks 13–52) | Ten milligrams: more side effects, not more benefit | Randomized trial |

Model. Individual results vary.
The efinopegdutide timeline’s milestones
The library’s timeline for efinopegdutide marks 4 points from week 1 to week 52, backed by moderate evidence overall.
- Week 1: Commonly reported: appetite dropping in the first days on 2 mg
- Week 4: The MASH trial stepped up every 4 weeks: 2, 4, 7, then 10 mg
- Week 24: Phase 2a: liver fat down about 73% at 10 mg vs 42% on semaglutide 1 mg
- Week 52: Phase 2b: liver inflammation resolved in 56% to 63% vs 13% on placebo
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why efinopegdutide takes that long
The library states no half-life with a number for efinopegdutide (it says: “Not reported in an open human PK source; dosed once weekly in all its trials”), so this page can’t work out a build-up; the timing rests on the notes above.
The notes on efinopegdutide follow the trials’ dose steps, 2mg, 4mg, 7mg and 10mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Efinopegdutide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, efinopegdutide among them; none of the others shares its onset of weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does efinopegdutide take to work?
Efinopegdutide’s onset is weeks, its peak effect comes at 24–52 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
When does efinopegdutide reach its peak effect?
By the library’s timeline, efinopegdutide’s peak effect comes at 24–52 weeks (trial endpoints), backed by moderate evidence.
How long is efinopegdutide usually run?
The library’s timeline gives efinopegdutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 24 to 52 weeks, stepping up every 4 weeks from 2 mg in the MASH trial.
What does the library say about the first days on efinopegdutide?
Its first note on efinopegdutide, for days 1–28 (weeks 1–4), is “A gentle first month”, resting on randomized trials.